Should anti-diabetic medications be reconsidered amid COVID-19 pandemic?

Affiliations

¹ Department of Endocrinology, Post Graduate Institute of Medical Education and Research, Chandigarh 160012, India.
² Department of Endocrinology, Post Graduate Institute of Medical Education and Research, Chandigarh 160012, India. Electronic address: bhadadask@gmail.com.

Rimesh Pal et al. Diabetes Res Clin Pract. 2020 May.

. 2020 May:163:108146.

doi: 10.1016/j.diabres.2020.108146. Epub 2020 Apr 10.

¹ Department of Endocrinology, Post Graduate Institute of Medical Education and Research, Chandigarh 160012, India.
² Department of Endocrinology, Post Graduate Institute of Medical Education and Research, Chandigarh 160012, India. Electronic address: bhadadask@gmail.com.

No abstract available

Keywords: Angiotensin-converting enzyme 2; COVID-19; Diabetes Mellitus; T2DM.

Conflict of interest statement

Declaration of Competing Interest The authors declare that they have no conflicts of interest.

COVID-19 and diabetes: Is metformin a friend or foe?
Ursini F, Ciaffi J, Landini MP, Meliconi R. Ursini F, et al. Diabetes Res Clin Pract. 2020 Jun;164:108167. doi: 10.1016/j.diabres.2020.108167. Epub 2020 Apr 24. Diabetes Res Clin Pract. 2020. PMID: 32339534 Free PMC article. No abstract available.
Comment on "Should anti-diabetic medications be reconsidered amid COVID-19 pandemic?".
Cure E, Cumhur Cure M. Cure E, et al. Diabetes Res Clin Pract. 2020 Jun;164:108184. doi: 10.1016/j.diabres.2020.108184. Epub 2020 Apr 30. Diabetes Res Clin Pract. 2020. PMID: 32360695 Free PMC article. No abstract available.

1. Coronavirus disease 2019 (COVID-19) Situation Report - 67. Accessed March 28, 2020. Available from: https://www.who.int/docs/default-source/coronaviruse/situation-reports/2....
1. Guan W, Ni Z, Hu Y, Liang W, Ou C, He J, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med [Internet]. 2020 [cited 2020 Mar 20]; Available from: http://www.nejm.org/doi/10.1056/NEJMoa2002032. - DOI - PMC - PubMed
1. Fang L, Karakiulakis G, Roth M. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? Lancet Respir Med [Internet]. 2020 [cited 2020 Mar 20]; Available from: https://linkinghub.elsevier.com/retrieve/pii/S2213260020301168. - PMC - PubMed
1. Salem E.S.B., Grobe N., Elased K.M. Insulin treatment attenuates renal ADAM17 and ACE2 shedding in diabetic Akita mice. Am J Physiol-Ren Physiol. 2014;306:F629–F639. - PMC - PubMed
1. Tripathy D., Daniele G., Fiorentino T.V., Perez-Cadena Z., Chavez-Velasquez A., Kamath S. Pioglitazone improves glucose metabolism and modulates skeletal muscle TIMP-3–TACE dyad in type 2 diabetes mellitus: a randomised, double-blind, placebo-controlled, mechanistic study. Diabetologia. 2013;56:2153–2163. - PubMed